Dear Customer,
on the occasion of the month dedicated to women's cancer prevention, Genomica is proud to promote an awareness campaign on such an important topic for women's health.

We are committed to facilitating access to crucial and high-level diagnostic tools, and for this reason, for the entire month of October, we are offering patients the opportunity to perform the OncoAdvance Risk BRCA Plus test at a reduced price, making it more accessible to all those who wish to evaluate their genetic risk.

OncoAdvance Risk BRCA Plus allows you to identify gene mutations associated with an increased risk of developing breast and ovarian cancer. In particular, the OncoAdvance Risk BRCA Plus test examines not only the BRCA1 and BRCA2 genes, but also the PTEN, PALB2 and BRP genes, also investigating the genes recommended by the AIOM (Italian Association of Medical Oncology) guidelines.

OncoAdvance Risk BRCA Plus therefore allows a more in-depth analysis of the gene variants that can influence the risk of developing these tumors. We believe that prevention requires awareness and access to reliable tests, which is why we offer not only the test at a reduced price, but also complete support throughout the process.

Genomica provides the expertise of its geneticists by offering:
• Free pre-test consultation
• Free post-test consultation: in the event of a positive result, our geneticists specialized in genetic counseling in the oncology field will be able to provide all the information necessary to better understand the next steps to take.

We hope that this initiative can be of great benefit to women and to those who are actively involved in promoting women's health.

We remain at your disposal and invite you to contact us for further information.

Contact Genomica

See you soon with new initiatives in the field of genetics.
The Genomica Team